INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) Is Trying To Revolutionize Cannabis Therapy





Midway through August, we took a look at INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) as part of this piece. At the time, the company had just reported data from some animal model studies of its lead development compound, a drug called INM-750, which had been set up to investigate the potential efficacy of the asset in a target indication of myofascial temporomandibular disorders (a chronic pain in the sensitive parts of muscles).

IMLFF Daily Chart... read more at: https://insiderfinancial.com/inmed-pharmaceutic-com-npv-otcmktsimlff-is-trying-to-revolutionize-cannabis-therapy

by

Leave a Reply

Your email address will not be published. Required fields are marked *